Back to People

Corinne S. Hockman Associate

Save current page as PDF
Raleigh T +1 919 755 6572 F fax +1 919 835 5943
Houston T +1 713 353 6692
vCard

Cori is an experienced trial attorney who focuses on patent, intellectual property, and commercial litigation, with an emphasis on technology-based disputes. Cori’s technical background enables her to regularly assist clients across a wide range of industries develop and execute successful litigation and pre-litigation dispute strategy, defend against intellectual property challenges, and secure their most valuable intellectual property assets.  Cori has tried multiple cases in federal court, won numerous dispositive motions, and represented clients in state and federal courts across the country.

Early in her career, Cori has already acquired significant courtroom and trial experience and has experience in in-court witness examination, writing dispositive motions and critical briefs, taking and defending depositions, managing discovery, and post-hearing and trial briefing in patent infringement, complex commercial, and civil rights litigation cases. Cori also has appellate experience in both state and federal courts in patent, complex commercial, and constitutional litigation.

Cori has experience representing and counseling clients on an array of intellectual property and commercial matters, including patent litigation, Patent Trial and Appeal Board (PTAB) inter partes review proceedings, IP due diligence, trade secret, and technology-based commercial disputes. Cori has represented both plaintiffs and defendants in a wide range of industries, including pharmaceuticals, medical devices, telecommunications, mobile devices, consumer products, and oil and gas.

Cori also maintains a robust pro bono practice. She was part of the trial and appellate team for Valentine v. Collier, which obtained the first permanent injunction during the COVID-19 pandemic securing protective measures and testing for elderly inmates in Texas. During trial, Cori took a key role in conducting the direct examination of the inmates’ primary medical expert witness. In addition, Cori has represented, counseled, and advised pro bono clients on a variety of legal issues including affirmative and defensive asylum matters, veterans’ issues, family, housing, and estate planning matters, and the representation of students with disabilities.

Prior to joining McGuireWoods, Cori completed judicial internships with Judge Jimmie V. Reyna of the U.S. Court of Appeals for the Federal Circuit and with Chief Judge Susan G. Braden of the U.S. Court of Federal Claims.

Experience

Intellectual Property Litigations

  • Represented several top banking institutions in patent litigations involving data backup and security technologies for customer account data (E.D. Tex.).
  • Represented construction, mining, and engineering equipment manufacturer in patent litigation involving large-scale generator assemblies (W.D. Tex.).
  • Represented online travel agency, and online tour and activity retailer in trademark infringement action and successfully obtained early dismissal for the clients (W.D.N.C.).
  • Represented a generic pharmaceutical manufacturer in Hatch-Waxman Litigation regarding client’s ANDA to make a generic version of Restasis®, indicated for dry eye treatment (E.D. Tex.).
  • Represented generic pharmaceutical manufacturers in Hatch-Waxman litigations relating to client’s ANDA to make a generic version of opioid dependence drugs, including the sublingual strip Suboxone® (buprenorphine and naloxone) (D. Del., D.N.J.).
  • Represented generic pharmaceutical manufacturer in Hatch-Waxman litigation regarding client’s ANDA to make a generic version of the drug Dificid® (fidaxomicin), indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) (D.N.J.).
  • Represented generic pharmaceutical manufacturer in Hatch-Waxman litigation regarding client’s ANDA to make a generic version of the oral solution Xywav® (calcium, magnesium, potassium, and sodium oxybates) (D.N.J.).
  • Represented generic pharmaceutical manufacturer in Hatch-Waxman litigation regarding client’s ANDA to make a generic version of the oral contraceptive Slynd® (progstin-only oral contraceptive) (D.Del.).
  • Represented generic pharmaceutical manufacturer in Hatch-Waxman litigation regarding client’s ANDA to make a generic version of the drug Biktarvy® (Bictegravir/emtricitabine/tenofovir alafenamide),vindicated for the treatment of HIV/AIDS (D.Del.).
  • Represented generic pharmaceutical manufacturer in Hatch-Waxman litigation regarding client’s ANDA to make a generic version of the oral contraceptive Balcoltra® (D.Del.).
  • Represented a leading medical device company in defending against a patent infringement case concerning spinal implants and related medical devices used for implantation (S.D. Cal.).
  • Represented multiple financial institutions in a patent litigation relating to data security systems (E.D. Tex.).
  • Represented a major telecommunications company in a patent litigation relating to text messaging and LTE technologies (E.D. Tex.).
  • Represented a major telecommunications company in a patent litigation involving wireless emergency alert systems (E.D. Tex.).
  • Represented hospitality company in patent litigation involving mobile and web browser search functionality, website user interface and display settings, and data analytics software (E.D. Tex.; N.D. Tex.).
  • Represented a financial institution in a patent litigation relating to mobile banking technology resulting in a victorious outcome confirmed by the Federal Circuit (N.D. Tex., Fed. Cir.).
  • Represented erosion prevention company in Lanham Act, patent licensing, and trade secret dispute against a former employee and competitor in parallel federal and state court actions (S.D. Tex., Harris County, Texas District Court, and Louisiana state court).
  • Represented a major oilfield services (OFS) supplier in a trade secret litigation in federal court in Houston and successfully obtained early dismissal through federal copyright and patent preemption rulings (S.D. Tex.).
  • Represented an OFS supplier in patent litigation involved hydraulic fracturing pump technology (N.D. Tex.).
  • Represented consumer goods manufacturer in Lanham Act, defamation, and unfair competition litigation (N.D. Cal.).
  • Represented an OFS supplier in successfully prosecuting several trade secret and breach of contract cases against current and former employees who misappropriated valuable proprietary information and breached non-competition, non-solicitation, and non-disclosure clauses (Fort Bend County, Texas District Court).
  • Represented various clients in conducting trade secret pre-suit investigations leading to the return of valuable data and enforcement of non-compete, non-solicitation, and non-disclosure provisions.

Complex Commercial Litigation & Arbitration

  • Represented a major OFS supplier in a $200 million-plus dispute regarding the operation of deep-water safety valves in the Southern District of Texas and obtained successful judgment after trial (S.D. Tex., 5th Cir.).
  • Represented gas utility in multimillion-dollar mass tort dispute in North Carolina state court (Durham County Superior Court).
  • Represented financial institution in Federal Credit Reporting Act litigation in District of New Jersey (D.N.J.).
  • Represented an OFS supplier in a multimillion-dollar oilfield equipment contract dispute in Texas state court and argued and obtained full summary judgment (Harris County, Texas District Court).
  • Represented an OFS supplier in a multimillion-dollar contract dispute concerning seismic equipment in a Houston-based arbitration and obtained a successful result (AAA).

Appeals

  • (U.S.) – Submitted certiorari-stage amicus brief on behalf of biosimilar company in
    Teva Pharm. USA, Inc. v. GlaxoSmithKline, LLC, No. 22-37 (2022).
  • (U.S.), (5th Cir.) – Acted as counsel in multiple applications to the U.S. Supreme Court in connection with stays of injunctions and was a key contributor to merits briefing before the Fifth Circuit (Valentine v. Collier, 140 S.Ct. 1598 (2020)).
  • (5th Cir.) – Successfully defended a trial court judgment in favor of a major OFS supplier in a major contractual dispute regarding the operation of deep-water safety valves in the Gulf of Mexico and the proper application of certain American Petroleum Institute standards (Hess Corp. v. Schlumberger Tech. Corp., 26 F.4th 229 (5th Cir. 2022)).
  • (Tex. App.—Eastland) – Successfully defended the trial court’s dismissal of all claims in an environmental action against an OFS client following mandamus from the court of appeals compelling the dismissal based on the law-of-the-case doctrine.
  • (5th Cir.) – Obtained favorable rulings from the U.S. Court of Appeals for the Fifth Circuit in a constitutional law case by serving as a key contributor to preliminary injunction stay and merits briefing.
  • (Tex. App.—Eastland) – Obtained mandamus from the Eleventh District Court of Appeals on behalf of a major OFS company, resulting in the complete dismissal of a large environmental action.
  • (Fed. Cir.) – Acted as counsel and briefed appeal from judgment of Delaware district court judge on behalf of a generic pharmaceutical company challenging a finding of infringement.

News

More News